A new report by XploreMR studies the growth drivers, trends, restraints, and highlights of the global artificial saliva market. Presenting exclusive insights into the market from 2017 to 2025, the report projects that the market will witness notable growth during the forecast period. As an effect of cancer and the subsequent radiations or chemotherapy treatments, the incidence of dry mouth has significantly increased. Artificial saliva - which is available in different forms such as, oral sprays, oral gels, and oral liquids - is used to treat the dry mouth. The growth of the market is primarily driven by increased spending on oral care, high adoption in treating oral diseases, and increasing levels of disposable income. Besides, dry mouth is often associated with aging, and as the global geriatric population rises, the demand for artificial saliva is expected to propel in the forthcoming years.

Heightened Emphasis and Increased Spending on Oral Care Uplift Market Growth

The majority of patients undergoing cancer treatment develop dry mouth as a result of dysphagia. On this premise, artificial saliva helps in reducing the symptoms of dysphagia and offers comfort to the patients. The growing incidence of cancer will continue to offer revenue opportunities to the artificial saliva market. Besides, dysphagia is highly prevalent among the aging population in developed regions, such as Europe, North America, and Japan, and this is also expected to drive the demand for artificial saliva products. On the other hand, the increased spending by consumers on oral care is directly responsible for the growth of the artificial saliva market. Being easy to use, oral gels and oral liquids are gaining remarkable traction among consumers. Moreover, oral gels, oral sprays, and oral liquids help in promoting compliance since they have higher compliance than tablets with oral sprays poised for tremendous adoption. Moreover, artificial saliva products have fewer side effects and fewer complications, and this is expected to fuel the adoption of the products in the forthcoming years. However, the availability of cheaper alternatives, such as herbal medicines, acupuncture, and salivary stimulants, is expected to restrain market growth. Additionally, research and development (R&D) activities to develop artificial salivary glands that prevent salivary damage is expected to hamper the growth prospects to an extent.

North America Exhibits Undisputed Hegemony

North America is anticipated to dominate the regional landscape of the artificial saliva market, owing to high spending and emphasis on oral care among consumers. The dominance of the region is also attributed to the easy availability of artificial saliva products, and the presence of large consumer and strong medical infrastructure. Along similar lines, the European region is also exhibiting tremendous growth and is bestowing the lucrative opportunities to the players in the market, backed by awareness among consumers.